Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Mahr

Showing results (81-90 of 158) with videos related to

Pageof 16
Sort By:
Arthritis Care & Research|November 17, 2020
Core Set of Domains for Outcome Measures in Behçet's SyndromeGülen Hatemi, Alexa Meara, Yesim Özgüler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 8, 2023
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitisBeatriz Sánchez Álamo, Laura Moi, Ingeborg Bajema, et al.
The New England Journal of Medicine|November 14, 2019
Trial of Apremilast for Oral Ulcers in Behçet's SyndromeGülen Hatemi, Alfred Mahr, Yoshiaki Ishigatsubo, et al.
Rheumatology (Oxford, England)|August 14, 2014
Gender-specific differences in Adamantiades-Behçet's disease manifestations: an analysis of the German registry and meta-analysis of data from the literatureNikolaos G Bonitsis, Liem B Luong Nguyen, Michael P LaValley, et al.
Clinical and Experimental Rheumatology|October 8, 2021
Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trialGülen Hatemi, Alfred Mahr, Mitsuhiro Takeno, et al.
Annals of the Rheumatic Diseases|September 11, 2012
Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysisAlfred Mahr, Sandrine Katsahian, Hugo Varet, et al.
Arthritis Care & Research|November 19, 2016
Dietary and Nondietary Triggers of Oral Ulcer Recurrences in Behçet's DiseaseGeoffroy Volle, Jean-Baptiste Fraison, Delphine Gobert, et al.
Rheumatology (Oxford, England)|June 25, 2015
Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study GroupSébastien Humbert, Philippe Guilpain, Xavier Puéchal, et al.
RMD Open|November 2, 2019
Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitisAna F Águeda, Sara Monti, Raashid Ahmed Luqmani, et al.
Seminars in Arthritis and Rheumatism|November 1, 2020
Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature reviewSara Monti, Kaitlin A Quinn, Robin Christensen, et al.
Pageof 16

Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Arthritis Care & Research|November 17, 2020
Core Set of Domains for Outcome Measures in Behçet's SyndromeGülen Hatemi, Alexa Meara, Yesim Özgüler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 8, 2023
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitisBeatriz Sánchez Álamo, Laura Moi, Ingeborg Bajema, et al.
The New England Journal of Medicine|November 14, 2019
Trial of Apremilast for Oral Ulcers in Behçet's SyndromeGülen Hatemi, Alfred Mahr, Yoshiaki Ishigatsubo, et al.
Rheumatology (Oxford, England)|August 14, 2014
Gender-specific differences in Adamantiades-Behçet's disease manifestations: an analysis of the German registry and meta-analysis of data from the literatureNikolaos G Bonitsis, Liem B Luong Nguyen, Michael P LaValley, et al.
Clinical and Experimental Rheumatology|October 8, 2021
Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trialGülen Hatemi, Alfred Mahr, Mitsuhiro Takeno, et al.
Annals of the Rheumatic Diseases|September 11, 2012
Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysisAlfred Mahr, Sandrine Katsahian, Hugo Varet, et al.
Arthritis Care & Research|November 19, 2016
Dietary and Nondietary Triggers of Oral Ulcer Recurrences in Behçet's DiseaseGeoffroy Volle, Jean-Baptiste Fraison, Delphine Gobert, et al.
Rheumatology (Oxford, England)|June 25, 2015
Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study GroupSébastien Humbert, Philippe Guilpain, Xavier Puéchal, et al.
RMD Open|November 2, 2019
Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitisAna F Águeda, Sara Monti, Raashid Ahmed Luqmani, et al.
Seminars in Arthritis and Rheumatism|November 1, 2020
Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature reviewSara Monti, Kaitlin A Quinn, Robin Christensen, et al.
Pageof 16